Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...
Maravai Lifesciences price target lowered to $7 from $10 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Maravai Lifesciences (MRVI) to $7 from $10 and keeps an Equal Weight rating on the ...
Business Insider1d
Hold Rating on Maravai Lifesciences: Revenue Miss, Guidance Cut, and Market Challenges Amid Potential Upside from Officinae Bio Acquisition
Tejas Savant, an analyst from Morgan Stanley, maintained the Hold rating on Maravai Lifesciences Holdings (MRVI – Research Report). The associated price target was lowered to $7.00. Tejas Savant has ...
Fintel on MSN2d
William Blair Downgrades Maravai LifeSciences Holdings (MRVI)
Fintel reports that on November 8, 2024, William Blair downgraded their outlook for Maravai LifeSciences Holdings ...
MarketWatch2d
Maravai LifeSciences Shares Plunge 39% After Guidance Cut, 3Q Miss
Shares of Maravai LifeSciences tumbled after third-quarter results ... The San Diego company, which provides reagents and other services for life sciences research, said after the close on Thursday ...